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Pluripotent embryonic stem cells (ESCs) maintain
self-renewalwhile ensuringa rapid response todiffer-
entiation cues. The identification of genes maintain-
ing ESC identity is important to develop these cells
for their potential therapeutic use. Here we report
a genome-scale RNAi screen for a global survey of
genes affecting ESC identity via alteration of Oct4
expression. Factors with the strongest effect on
Oct4 expression included components of the Paf1
complex, a protein complex associated with RNA
polymerase II. Using a combination of proteomics,
expression profiling, and chromatin immunoprecipi-
tation, we demonstrate that the Paf1C binds to
promoters of key pluripotency genes, where it is
required to maintain a transcriptionally active chro-
matin structure. The Paf1C is developmentally regu-
lated and blocks ESC differentiation upon overex-
pression, and the knockdown in ESCs causes
expression changes similar to Oct4 or Nanog deple-
tions. We propose that the Paf1C plays an important
role in maintaining ESC identity.
INTRODUCTION
Embryonic stem cells (ESCs) have unlimited capacity for self-
renewal and can be kept undifferentiated for many passages
under appropriate conditions while maintaining the competence
to generate a wide range of cell types upon differentiation
(Chambers and Smith, 2004). Because of these distinctive prop-
erties, ESCs are widely used for studies of developmental
processes (O’Shea, 2004). The potential to differentiate into
many cell types also makes ESCs a starting point for potential
cell-based therapies (Keller, 2005). However, a systematicmolecular understanding of self-renewal and differentiation is
required to harness the full potential of ESCs.
Several transcription factors that contribute to the regulation
of self-renewal and differentiation of ESCs have been identified.
Oct4, Nanog, and Sox2 form a transcriptional core unit upon
which ESC pluripotency is critically dependent (Silva and Smith,
2008). Recently, an RNAi analysis of 70 candidate transcription
factors identified roles for additional genes, including Tbx3,
Esrrb, Tcl1, and Dppa4, in the maintenance of ESC pluripotency
(Ivanova et al., 2006). Depletion of these genes negatively
affected self-renewal, and induced ESC differentiation.
Several signaling pathways including the LIF/Stat3, PI3K, Wnt,
and Bmp/Smad pathways also contribute to the regulation of
self-renewal and differentiation of ESCs. For example, the PI3K
pathway regulates multiple cascades including Ras/MAPK and
mTOR pathways, which are essential for proliferation of mouse
ESCs (Takahashi et al., 2005).
In addition to transcription factors and signaling pathways,
a defined epigenetic state has been shown to be essential to
maintain ESC identity (Pietersen and van Lohuizen, 2008).
Accordingly, many promoters of key developmental genes
including Sox, Hox, Pax, and Pou gene family members display
both an activating (H3K4me) and a repressive (H3K27me)
histone mark on the nucleosomes at their promoters in ESCs
(Bernstein et al., 2006). This ‘‘bivalent’’ histone code silences
lineage-control gene expression due to the dominant effect of
H3K27me over H3K4me, while preserving their potential to be
rapidly activated upon differentiation stimuli via the removal of
the H3K27me mark. It is therefore not surprising that proteins,
which regulate chromatin structure, are important for ESC iden-
tity, as recently shown by a focused RNAi screen of1000 chro-
matin proteins (Fazzio et al., 2008).
The work performed on transcription factors, signaling, and
chromatin has substantially improved our understanding of
ESCs. However, our knowledge of how these processes are
connected is still limited. A global survey of genes essential for
ESC self-renewal and identity would not only advance our
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also help to develop better protocols for directed differentiation
of ESCs for their potential therapeutic use.
To obtain a more systematic understanding of the genes asso-
ciated with ESC identity, we performed a genome-scale RNAi
screen in mouse ESCs using an Oct4 reporter assay as a surro-
gate for ESC identity. We identified many novel genes that
affected Oct4 expression and therefore ESC identity and
analyzed one group of genes, which form the Paf1 complex
(Paf1C), in more detail. Our work therefore expands the inventory
of genes required to maintain ESC identity and defines a role of
Figure 1. Genome-Scale esiRNA Screen
(A) Flow diagram of the screening strategy to iden-
tify genes essential for mouse ESC identity. Eight
negative controls (boxed in green), eight positive
controls (four GFP esiRNA, red; and four Sox2
esiRNA, orange), three primary hits (blue), and
one random well without a phenotypic conse-
quence (black) are highlighted. The red color
intensity reflects the strength of phenotypes
observed in each well, which is illustrated by
FACS readouts for two exemplified wells (boxes
below the plates).
(B) Dot plot of the primary screen results. The
average Z scores of the GFP readouts are shown.
The dotted lines indicate Z score > 2 or < 2. The
solid line marks Z scores > 4. Validated genes with
Z scores > 3 with a second, independent esiRNA
are shown as red squares. Selected pluripotency
genes that scored with a Z score > 2 are shown
as blue triangles.
the Paf1C in maintaining active transcrip-
tion of pluripotency genes in ESCs.
RESULTS
Primary Screen for Oct4
Modulators
To perform an RNAi screen in mouse
ESCs, we generated a genome-scale
mouse endoribonuclease prepared
(e)siRNA library containing 25057
esiRNAs (see Table S1 available online)
using the established esiRNA synthesis
protocol (Kittler et al., 2005a). EsiRNAs
have proven efficacy and specificity in
human cells (Kittler et al., 2004, 2007a,
2007b), suggesting that this resource
should be useful for RNAi screening in
mouse cells. To identify genes essential
for the maintenance of ESC identity, we
developed a rapid and robust assay
amenable to high-throughput detection
of differentiation triggered by RNAi (Fig-
ure 1A). Oct4 expression is a hallmark of
ESC identity, and constant expression
levels of Oct4 are required for self-renewal
of ESCs (Niwa et al., 2000). Depletion of
Oct4 in ESCs via knockout or RNAi leads to exit from self-renewal
and to differentiation (Carpenter and Zernicka-Goetz, 2004;
Nichols et al., 1998). In turn, the expression of Oct4 is rapidly
switched off in differentiating cells during embryonic develop-
ment (Pesce and Scholer, 2001). Hence, Oct4 expression levels
can be used to monitor the differentiation status of ESCs.
We used an Oct4 reporter cell line (Oct4-Gip) in which the
expression of GFP is controlled by Oct4 regulatory elements to
establish an assay for analyses of ESC identity (Ying et al.,
2002). Quantification of GFP fluorescence faithfully reflects the
self-renewal and differentiation status in individual cells and404 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.
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required for ESC identity (Figure 1A). To test the reliability of this
assay, we transfected the Oct4-Gip cells with control esiRNA
(Luc) and esiRNAs directed against known pluripotency genes,
including Sox2, Stat3, and Oct4. The ratio of GFP-positive
versus GFP-negative cells was determined by microscopy and
by flow cytometry 96 hr posttransfection. In both cases, a loss
of GFP expression was readily detected upon Sox2, Stat3, and
Oct4 depletion, which coincided with differentiation of these
cells (Figure S1). In contrast, no loss of GFP expression or differ-
entiation was observed when the cells were transfected with the
control esiRNA. To rule out the possibility that essential genes
that are not required for ESC self-renewal, but are required for
general cell growth and viability, would score in this assay, we
transfected the Oct4-Gip cells with esiRNAs targeting genes
with housekeeping functions, such as ribosomal, proteasomal,
mitochondrial, and Pol II subunits. As expected, depletion of
housekeeping genes strongly affected cell viability (Figure S1).
However, none of these esiRNAs caused a significant loss of
GFP-positive cells, demonstrating that this assay is highly
specific to identify genes affecting ESC identity.
The screen was carried out in duplicate using a high-
throughput FACS-based readout. EsiRNAs that reproducibly
scored were identified using statistical methods (see the Supple-
mental Data for details). We nominated 296 esiRNAs, which
significantly regulated GFP expression (Z score > 2, or Z score <
2) from the primary screen (Figure 1B, Table S1). GO term
analysis indicated that transcription factors (25 genes) and
gene expression regulators (51 genes) were significantly en-
riched in the primary hit list (p < 0.05), suggesting that this subset
of genes can be a rich starting point to dissect the regulation of
self-renewal and early differentiation of mouse ESCs.
The Screen Identified Known and Discovered
Novel Candidate Pluripotency Genes
Many known pluripotency-controlling genes including Oct4,
Sox2, Stat3, PI3K, Set1b, and Wdr5 scored with significant Z
scores, demonstrating the effectiveness of the screen. We also
identified many additional genes that have been linked to ESC
biology, such as direct Oct4 and Nanog target genes (Cxxc1,
Vti1a, Nfix, Etv1, Rad21, Ina, Cdh4, Spred2, Bach2, Myh9,
Map3k7, Tcf12) (Fouse et al., 2008) and genes that are regulated
by Oct4 and Nanog (Rnf2, Ncl, Ina, Spred2, Thbs3, Ell2, Tmem4,
Etv1, Foxp1) (Loh et al., 2006). Some known pluripotency genes,
including Esrrb, Tbx3, and Klf4, did not score significantly in the
primary screen, possibly reflecting insufficient knockdown,
redundancy, or that their roles in ESC identity are not reflected
in Oct4 expression levels.
For this study, we concentrated on the genes with the stron-
gest phenotypic scores (Z score > 4) and validated the pheno-
type of these candidates with a second, independent esiRNA.
Twenty-nine independent esiRNAs were successfully synthe-
sized (Table S2) and transfected into the Oct4-Gip ESCs.
Twenty-one of these caused a reduction of GFP expression
greater than two times the standard deviation, validating their
role in maintaining Oct4-driven GFP expression (Table S2).
Sixteen hits with Z scores above three were further analyzed.
Gene ontology analyses placed these genes into different func-
tional classes, including transcription regulation (Nfya, Ptbp1,Ctr9, Rtf1, Wdr61, Cpsf3, Fip1l1, Iws1, Thoc2), chromatin modu-
lation (Rnf2, Cxxc1, Cnot1, Rtf1, Ctr9, Wdr61, Ncl), signaling
(Apc), and protein degradation/DNA repair (Ube2m, Shfdg1).
Self-Renewal Assays
To substantiate a direct role of the 16 candidate genes in ESC
identity, we performed three additional, independent self-
renewal assays. First, we evaluated changes in cell morphology
and alkaline phosphatase (AP) staining after esiRNA transfec-
tion. For the negative control (Luc)-transfected ESCs, nearly all
of the colonies showed an undifferentiated morphology and
highly positive AP staining (Figure 2A). In contrast, knockdown
of most candidates resulted in reduced AP staining and obvious
morphological changes in the Oct4-Gip cells, demonstrating the
loss of pluripotency along with differentiation (Figure 2A,
Figure S2). To exclude the possibility that these effects are
Oct4-Gip cell-type specific, we performed the same experi-
ments in R1/E ESCs and obtained identical results (Figure S2
and data not shown).
Second, we analyzed changes in cell-cycle profiles upon RNAi.
Transfection of all tested esiRNAs lead to a reduction of cells in S
phase (Figure 2B), demonstrating a change of cell-cycle regula-
tion and consistent with an exit of these cells from self-renewal.
Third, we quantified endogenous Oct4 and Nanog transcript
levels by qRT-PCR after esiRNA transfections. The transfection
of all esiRNAs led to a reduction of Oct4 expression with 12
knockdowns, resulting in a significant (p < 0.05) or highly signif-
icant (p < 0.01) decrease of Oct4 transcript levels (Figure 2C),
demonstrating that the Oct4-driven GFP expression closely
mimicked the endogenous Oct4 expression. Many candidates
also reduced Nanog expression (Figure 2D), albeit to a lower
extent, possibly reflecting that some knockdowns primarily
affect Oct4 expression. To test whether knockdown of the candi-
date genes induced ESC differentiation by interfering with the
LIF/Stat3 cascade, we analyzed Stat3 and phosphorylated-
Stat3 (Stat3-P) levels. We observed no obvious change of
Stat3 and Stat3-P protein levels for the knockdowns, indicating
that the loss of ESC identify was not mediated through perturb-
ing the LIF/Stat3 pathway (Figure 2E). Collectively, these results
suggest that candidate genes directly affect ESC identity
through reduction of Oct4 levels.
The Paf1C Is Essential for ESC Identity
Among the validated knockdowns strongly reducing Oct4 levels
in ESCs were the genes Rtf1 and Ctr9 (Figure 1B), two compo-
nents of the Pol II-associating factor 1 complex (Paf1C). The
Paf1C, minimally composed of Paf1, Ctr9, Cdc73, Rtf1, and
Leo1, has been implicated in multiple processes such as tran-
scription initiation and elongation, transcript start site selection,
and RNA processing (Costa and Arndt, 2000; Penheiter et al.,
2005; Stolinski et al., 1997). In addition, the Paf1C has been
linked to histone modifications in different organisms (Adelman
et al., 2006; Krogan et al., 2003) through a stimulation of H2B
ubiquitination (Ng et al., 2003a), coupling Pol II elongation with
SET1 and SET2 activities (Carrozza et al., 2005; Krogan et al.,
2003; Ng et al., 2003b). Because of its potential role for the regu-
lation of ESC chromatin and because two independent compo-
nents of this protein complex were among the top hits, we
selected the Paf1C for further analysis.Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc. 405
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(A) AP staining of ESCs 4 days after treatment with indicated esiRNAs. Note the loss of staining and the morphological changes of cells transfected with esiRNAs
against Wdr61, Ptbp1, Ube2m, Ctr9, Rtf1, Cpsf3, and Iws1. Scale bars, 200 mm.
(B) Cell-cycle analysis of ESCs after gene knockdown. Cell profiles recorded 4 days after transfection with indicated esiRNAs are shown. The percentage of cells
in S phase is indicated above each graph.
(C) Quantification of endogenous Oct4 transcript levels. qRT-PCR analysis performed 4 days after esiRNA transfection with indicated esiRNAs are shown.
(D) Quantification of Nanog transcript levels. qRT-PCR analysis performed 4 days after esiRNA transfection with indicated esiRNAs are shown.
(E) Analysis of Stat3 and Stat3-P protein levels. Protein extracts prepared from ESCs 4 days after transfection with indicated esiRNAs, and analyzed by immu-
noblotting with anti-Stat3, anti-Stat3-P, and anti-Gapdh (loading control) antibodies are presented. Cells grown for 4 days without LIF (LIF) are shown as a posi-
tive control. (C and D) All values are means ± SD from at least triplicate experiments. * indicates significant (p < 0.05) and ** highly significant (p < 0.01) results
based on Student’s t test analyses.To test whether the whole Paf1C is required for ESC identity,
we knocked down the expression of the remaining known
Paf1C components (Paf1, Leo1, and Cdc73) in ESCs with two
independent esiRNAs and found differentiation phenotypes
and decreased Oct4 expression levels similar to those observed
upon Ctr9 and Rtf1 knockdown (Figures 3A and 3B and data not
shown), demonstrating that the whole Paf1C is required to main-
tain ESC identity.
To further validate the role of the Paf1C for ESC identity, we
performed cross-species RNAi rescue experiments (Kittler
et al., 2005b) for three of the Paf1C components (Figures 3C–
3E). Stable expression at physiological levels of the human
Ctr9, Rtf1, and Leo1 genes in mouse ESCs rendered these cell
lines resistant to the corresponding esiRNAs, but not to the
esiRNAs targeting the other Paf1C components. Therefore, the
human Ctr9, Rtf1, and Leo1 genes function in mouse ESCs and
can substitute their mouse orthologs. More importantly, these
results manifest an essential role of the Paf1C for ESC identity.
Paf1C Affects the Expression of Pluripotency
and Lineage-Marker Genes
Next, we analyzed global transcript changes upon Paf1C deple-
tion. For this purpose, we transfected ESCs with esiRNAs target-406 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.ing Ctr9, a core component of the Paf1C (Adelman et al., 2006),
and control esiRNA (Luc) and analyzed transcript changes using
microarrays. This analysis identified a total of 1139 genes whose
expression was perturbed significantly (p < 0.0001) after treat-
ment with Ctr9 esiRNA (Table S3), with 529 and 610 genes down-
regulated or upregulated, respectively, suggesting that the
Paf1C both activates and represses target genes. GO term anal-
ysis of these genes indicated that genes implicated in biological
processes relevant to embryonic development such as cell
morphology and motility, cell-cycle control, cell proliferation
and differentiation, oncogenesis, and ectoderm and mesoderm
formation were highly enriched (Table S4). Intriguingly, most
known key regulators of pluripotency in ESCs, such as Nanog,
Oct4, Tbx3, Esrrb Bmp4, Tcl1, Klf4, and Klf5 were downregu-
lated upon Ctr9 depletion. In contrast, many lineage-control
genes were strongly upregulated (Figure 3F), suggesting that
the Ctr9 knockdown induced extensive differentiation. For
example, ectoderm marker Fst increased 2-fold, and mesoderm
markers Lef1 and Mest were upregulated 2.6-fold and 1.8-fold,
respectively, indicating differentiation of the cells toward these
lineages. Differentiation of the cells was also confirmed by moni-
toring Fgf5 protein levels in cells transfected with Ctr9 esiRNA,
as measured by immunostaining with an Fgf5 antibody and
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ingly, we did not observe an upregulation of any gene implicated
in endoderm development, suggesting lineage-restricted differ-
entiation upon Ctr9 depletion.
To determine whether depletion of other Paf1C components
results in similar expression changes, we knocked down Paf1,
Rtf1, Leo1, and Cdc73 in ESCs and determined the expression
changes of selected pluripotency and lineage-marker genes by
qRT-PCR. Consistent with the Ctr9 microarray data, the knock-
down of all other Paf1C components induced similar expression
changes (Figure 3B) and hence validated the downregulation of
pluripotency genes and upregulation of specific lineage-control
genes upon Paf1C depletion. The induced expression of tro-
phectoderm, ectoderm, and mesoderm, but not endoderm
markers, suggests that regulation of the Paf1C in the early
mouse embryo may contribute to lineage specification. To test
whether the observed lineage-restricted differentiation is Paf1C
specific, we tested the regulation of lineage-control genes
upon knockdown of three other candidate genes (Shfdg1,
Cnot1, and Ube2m) identified in the primary screen. These three
knockdowns induced the expression of lineage markers,
including endoderm markers Gata6 and Sox17 (Figure 3G), indi-
cating that lineage-restricted differentiation is not generally
observed upon knockdown of Oct4 modulators. In fact, the
knockdown of Ube2m showed an upregulation of Gata6 and
Sox17 only, indicating that the knockdown of Ube2m leads to
endoderm-specific differentiation.
Depletion of the Paf1C by RNAi resulted in downregulation of
both Oct4 and Nanog, suggesting that the Paf1C may be part of
the Oct4-Nanog transcription circuit. Therefore, we compared
the gene expression profiles upon Ctr9 knockdown to those
obtained for Oct4 and Nanog knockdown (Loh et al., 2006).
We compared all genes regulated with a stringent cutoff (p <
0.0001) and found a marked overlap between the Ctr9, Oct4,
and Nanog knockdown profiles (Figure 3H; Table S6), with Pear-
son test correlation coefficients of 0.45 (Ctr9 versus Oct4), 0.50
(Ctr9 versus Nanog), and 0.58 (Oct4 versus Nanog). One
hundred thirty genes were significantly regulated for all three
knockdowns (Table S6). Importantly, genes that were signifi-
cantly downregulated included the pluripotency genes Nanog,
Esrrb, Tcl1, Bmp4, and Klf4.
Paf1C Binds to Promoters of Pluripotency Genes
To further study the function of Paf1C in mouse ESCs, we gener-
ated an ES line stably expressing a location and affinity purifica-
tion (Cheeseman and Desai, 2005) (LAP)-tagged Ctr9 fusion
protein using the bacterial artificial chromosome (BAC)-based
TransgeneOmics approach (Kittler et al., 2005b; Poser et al.,
2008). Fluorescence microscopy analysis of cell clones express-
ing Ctr9-LAP showed a punctate, nuclear localization (Figure S4),
consistent with a role of Ctr9 in regulating transcription/chro-
matin. To investigate whether pluripotency and lineage-control
genes differentially regulated upon Paf1C depletion are direct
targets of the Paf1C, we analyzed the binding of the Ctr9-LAP
fusion protein by ChIP-chip and identified 2175 promoter regions
that were bound by Ctr9 (Table S5). GO term analysis indicated
that genes bound by Ctr9 were enriched for processes relevant
for ESC biology, such as cell cycle, apoptosis, development, and
chromatin packaging and remodeling (Figure 4A). Notably, manygenes that are highly expressed in ESCs were not bound by the
Paf1C (e.g., Ubiquitin B, a-tubulin 2, Enolase 1, Hexokinase 1,
Calmodulin 2, etc.), suggesting that the Paf1C is not present at
promoters of all actively transcribed genes. A closer inspection
of genes falling into the developmental classification indicated
that promoters of many pluripotency genes, such as Oct4,
Nanog, and Sox2 were bound by the Paf1C (Figure 4B). The
comparison of genes that were downregulated upon Ctr9 RNAi
(see Figure 3 and Table S3) with genes that are bound by Ctr9
(Table S5) revealed a highly significant overlap (p value, 3.03e-
07) and included pluripotency genes such as Oct4 and Nanog.
Therefore, the Paf1C directly influences the expression of impor-
tant pluripotency genes.
To further investigate the binding of the Paf1C to pluripotency
and lineage commitment genes, we performed chromatin immu-
noprecipitation followed by quantitative PCR (ChIP-qPCR) of
selected genes. Marked Ctr9-LAP binding was observed 50
proximal to the transcription start sites and coding regions of
seven out of eight tested pluripotency genes (Figures 4C and
4D). This finding suggests that the Paf1C binds close to the tran-
scription initiation site of pluripotency genes in ESC and likely
travels alongside Pol II during elongation. In contrast, weak or
no signals were detected for most lineage-marker and house-
keeping genes. An exception was the gene Gata6, a marker for
endoderm development (Hay et al., 2004). We measured strong
Ctr9 binding at the Gata6 promoter, but no signal in the coding
region, indicating that the Paf1C occupies this promoter before
the gene is expressed. Collectively, these results suggest that
the Paf1C is a specific regulator of transcription for a subset of
genes, which in ESCs include many pluripotency genes.
Paf1C Is Required to Maintain the Chromatin
Structure of Pluripotency Genes in ESCs
A potential mechanism for Paf1C action on the promoters of plu-
ripotency genes may be the modulation of the local chromatin
structure. In yeast, the Paf1C has been implicated in multiple
aspects of histone methylation via the recruitment of methyl-
transferase complexes to Pol II (Krogan et al., 2003). To investi-
gate a potential role of the Paf1C for histone methylation in
mouse ESCs, we analyzed the effects of Ctr9 depletion on
histone modifications associated with actively transcribed
(H3K4 trimethylation or H3K4me3) and repressed (H3K27 trime-
thylation or H3K27me3) chromatin for promoter regions of
selected genes. ChIP-qPCR analyses indicated that H3K4me3
levels on promoters of pluripotency genes strongly decreased
upon Ctr9 depletion, suggesting that the Paf1C is required
for the maintenance of H3K4me3. For the lineage-control genes,
the H3K4me3 levels remained essentially unchanged, whereas
the H3K27me3 levels for the ectoderm and the mesoderm spec-
ification genes decreased markedly (Figures 4E and 4F). To
substantiate this finding, we performed Paf1C double knock-
downs with the trithorax group-like, Set1 complex subunit
gene, Cxxc1 (required for H3K4me3), and the polycomb group
Pc1 complex subunit gene, Rnf2/Ring1b (required for
H3K27me3), both of which individually affect ESC pluripotency
(Fazzio et al., 2008; Lee and Skalnik, 2005; Figure 1B). We
observed a robust enhancement of the phenotype when Ctr9
or Rtf1 was cosilenced together with Cxxc1, but no effect
when the same Paf1C subunits were cosilenced together withCell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc. 407
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(A) RNAi of all Paf1C components leads to downregulation of endogenous Oct4 expression. qRT-PCR quantifications of Oct4 expression levels 4 days posttrans-
fection of indicated esiRNAs are presented.
(B) RNAi of all Paf1C components induces similar lineage-restricted differentiation. qRT-PCR quantifications of indicated ectoderm (blue), mesoderm (green), and
endoderm (light and dark red) markers after transfection with indicated esiRNAs are shown.
(C) RNAi in human BAC-transgenic ESC lines specifically depletes the mouse transcripts. PCR fragments digested with a restriction enzyme discriminating
between the human and mouse transcripts are shown for human cells (HeLa), WT ESC (ESC), human BAC-transgenic ESCs (hBAC_ESC), and human BAC-trans-
genic ESCs transfected with indicated esiRNAs (hBAC_ESC + esiRNA), respectively. Note the reduced band intensities of the mouse product after esiRNA trans-
fections in the human BAC-transgenic ESCs. The 500 base pair (bp) band of the marker is shown on the left.
(D) Oct4 and lineage-marker expression analyses in human BAC-transgenic ESCs. qRT-PCR analysis of Oct4 (green), Cdx2 (yellow), and Fgf5 (blue) after trans-
fection of indicated esiRNAs in the indicated human BAC-transgenic ESC lines are shown. Note the rescue of the phenotypes in cell lines transfected with the
corresponding esiRNAs.
(E) Expression of the human gene in the mouse ESCs rescues the phenotypes. AP stainings of indicated ESC lines with indicated esiRNAs are shown.
(F) Expression changes of selected genes after Ctr9 depletion. Pluripotency genes (black), lineage-marker genes, ectoderm (blue), mesoderm (green), and endo-
derm (red) are plotted as log2(Ctr9/Luc) versus log10 (p value).408 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.
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levels and changes in the expression of the differentiation
markers Cdx2, Fgf5, and Brachyury indicated that the simulta-
neous depletion of Paf1C with Cxxc1 enhanced the expression
of these differentiation markers (Figure S5B). Together, these
results indicate that the Paf1C synergizes with the Set1 complex
to maintain ESC pluripotency and support a direct role of the
Paf1C in maintaining H3K4me3 at promoter regions of pluripo-
tency genes.
Proteomic Analyses of Paf1C in ESCs
The Paf1C is composed of at least five subunits, Paf1, Ctr9, Rtf1,
Cdc73, and Leo1. Recently, the human Paf1C complex has been
shown to interact with hSki8, a component of the SKI complex,
which together with the exosome mediates 30-50 mRNA degra-
dation (Zhu et al., 2005). This interaction suggests a possible
link of the human Paf1C to RNA quality control and extends
the proteins that comprise the human Paf1C. Interestingly, the
mouse ortholog of hSki8, Wdr61 was among the 16 validated
strongest hits in our primary screen (Figure 1B), suggesting
a potential role of this gene in mouse ESCs as a component of
the Paf1C.
To identify potential interaction partners of the Paf1C in ESCs,
we performed a proteomic analysis using the Ctr9-LAP and
a Leo1-LAP-tagged ESC line. Both lines express similar levels
of the LAP-tagged and the endogenous Paf1C transcripts
(Figure S4). After affinity purification with an anti-GFP antibody,
prey proteins were eluted and analyzed by mass spectrometry.
This analysis revealed most of the known Paf1C components
(Table 1). In addition, several Pol II-associated and chromatin-
modifying proteins were immunoprecipitated, including Pabc1,
Ruvbl1, Ruvbl2, Sfpq, Tceb3, Polr2a, Polr2e, CoREST, and
Smarce1, implying a complex interacting network of Paf1C
with other transcriptional and chromatin regulators. Importantly,
Wdr61 was identified as a Paf1C interaction partner by both
Ctr9-LAP and Leo1-LAP pulldowns, authenticating the interac-
tion of this protein with the Paf1C in mouse ESCs (Table 1). To
validate the interaction of Wdr61 with Paf1C, we generated
a Wdr61-LAP ESC line and analyzed its interaction partners via
mass spectrometry. The Wdr61-LAP pulldown identified two
Paf1C components, Cdc73 and Leo1, and the Pol II-associated
proteins Ruvbl1 and Ruvbl2, further validating the interaction
between Wdr61, the Paf1C, and several other transcriptional
regulators (Table 1). Similar knockdown phenotypes and
protein-protein interactions strongly suggest that Wdr61 func-
tions together with Paf1C to maintain ESC identity.
Paf1C Is Downregulated during Embryoid
Body Formation
To analyze possible expression changes of the Paf1C during
early development, we analyzed the expression of Paf1C
subunits during ESC differentiation in embryoid bodies (EBs).
For all Paf1C subunits, downregulated expression was observedduring the formation of EBs (Figure 5A), indicating that the Paf1C
is downregulated during early embryonic development. To test
whether the reduction in Paf1C subunit expression levels is
just part of a general decrease in the expression of Pol II-associ-
ated protein complexes during differentiation, we analyzed the
expression levels of subunits of the Pol II-associated mediator
complex in EBs (Myers and Kornberg, 2000). In contrast to the
Paf1C, transcript levels of the investigated mediator complex
subunits did not change significantly during EB formation
(Figure 5A). Hence, the downregulation of the Paf1C may be
important for proper embryonic development. Support for
a role of the Paf1C during development comes from observa-
tions in Drosophila and Zebrafish, in which a variety of embryonic
developmental defects have been described for Paf1C compo-
nent depletions (Akanuma et al., 2007; Tenney et al., 2006),
and from Cdc73 knockout mice, which develop normally up to
E3.5 but then die either at hatching or implantation (Wang
et al., 2008).
Paf1C Overexpression Blocks ESC Differentiation
Many pluripotency genes block differentiation when overex-
pressed (Turksen, 2001; Chambers et al., 2003). To test whether
overexpression of a Paf1C component can block ESC differenti-
ation, we transfected a Sox1-GFP reporter cell line (Aubert et al.,
2003) with tetracycline-inducible Ctr9 and control constructs
(Figures 5B and 5C). Sox1 is not expressed in undifferentiated
ESCs but is strongly induced during neuronal differentiation
(Aubert et al., 2003) and during cultivation in a neuronal growth
and differentiation medium (Diogo et al., 2008). Because we
observed a prominent activation of ectodermal genes upon
Paf1C RNAi, potentially overexpression of a Paf1C component
will block differentiation, as reported by the acquisition of
Sox1-GFP expression. Indeed, a marked reduction of GFP-
positive cells upon transfection of the Ctr9 construct was only
detected when tetracycline was present in the culture medium
(Figures 5D and 5E). A block of differentiation was further sup-
ported by analyses of the differentiation markers Fgf5 and Nestin
and the pluripotency factor Oct4 in these cells (Figure 5F). These
data demonstrate that an excess of a Paf1C component can
block the differentiation of ESCs.
DISCUSSION
A detailed molecular understanding on how genetic factors influ-
ence the balance between pluripotency and differentiation of
mammalian cells is crucial to develop ESCs for their potential
therapeutic use. This understanding is becoming increasingly
important because it is now possible to generate ESC-like cells
from somatic cells via direct reprogramming (reviewed in Jae-
nisch and Young, 2008), avoiding many ethical issues. In the
future it seems feasible to bank personalized iPS cells that
may be used to generate differentiated cells to replace damaged
tissue in the body when needed. Obviously, this scenario(G) Knockdown of Shfdg1, Cnot1, and Ube2m induces the expression of lineage markers, including endoderm. qRT-PCR quantifications of indicated genes with
indicated esiRNAs are shown.
(H) Venn diagram of the number of genes regulated by Ctr9, Oct4, and Nanog. The diagram shows the overlap of genes affected by Ctr9 (red), Oct4 (green), and
Nanog (yellow) knockdowns. (A, B, D, and G) All values are means ± SD from at least triplicate experiments. * indicates significant (p < 0.05) and ** highly signif-
icant (p < 0.01) results based on Student’s t test analyses.Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc. 409
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RNAi Screen Reveals Paf1C Affects ESC IdentityFigure 4. Ctr9 Binds to Promoters and Coding Regions of Pluripotency Genes and Is Required to Maintain the Chromatin Structure in ESCs
(A) ChIP-chip analysis of Ctr9 target genes. GO term enrichment analysis of selected overrepresented and underrepresented categories are presented.
(B) Ctr9-binding profiles of selected genes, extracted from the ChIP-chip experiments. The binding profiles of the pluripotency genes Oct4 and Nanog, the house-
keeping genes b-actin (Actb) and a-tubulin (Tuba1a), and the differentiation genes Fgf8 and Nkx2.2 are shown. Arrows indicate significant enrichment peaks for
Ctr9 binding. The genomic structure of the genes is shown below the profiles with an arrow indicating the predicted transcriptional start site. The relative expres-
sion of the genes in ESCs is shown to the right of each profile.
(C) Ctr9-ChIP-qPCR analysis at the promoter regions of indicated genes grouped for pluripotency (pluri), ectoderm (ecto), mesoderm (meso), endoderm (endo),
and nonlineage (nl) control genes. Log2 enrichment represents the abundance of enriched DNA fragments over mock controls.
(D) Ctr9-ChIP-qPCR analysis at the coding regions of indicated genes. Np; nonpluripotency genes.
(E) Depletion of Ctr9 results in a decrease of H3K4me3 on the promoters of pluripotency genes. ChIP assays for indicated genes are shown. Fold enrichment
represents the abundance of enriched DNA fragments over mock controls.
(F) Depletion of Ctr9 results in a decrease of H3K27me3 on the promoter of some lineage-control genes. ChIP assays for indicated genes are shown.
(G) Synthetic analysis of Paf1C components with Cxxc1 and Rnf2. FACS quantification of GFP-negative cells 4 days after transfection of Oct4-Gip ESCs with
indicated esiRNAs are shown. (C, D, E, F, and G) All values are means ± SD from at least triplicate experiments. * indicates significant (p < 0.05) and ** highly
significant (p < 0.01) results based on Student’s t test analyses.410 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.
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Baits Name Accession Number Mass Score Matches PEP_UNIQ SEQ_COV
Ctr9 Ctr9 IPI00477468 133,420 2,177 55 43 44%
Ctr9 Paf1 IPI00331654 60,481 1,140 28 23 54%
Ctr9 Cdc73 IPI00170345 60,539 1,116 28 25 52%
Ctr9 Leo1 IPI00474486 76,912 817 17 13 23%
Ctr9 Wdr61 IPI00112320 33,778 640 21 13 59%
Ctr9 Pabpc1 IPI00124287 70,626 414 8 8 17%
Ctr9 RuvB-like 1 IPI00133985 50,182 272 6 6 17%
Ctr9 COREST IPI00226581 53,272 201 4 4 12%
Ctr9 RuvB-like 2 IPI00123557 50,949 182 4 4 9%
Ctr9 SFPQ IPI00129430 75,394 148 3 3 7%
Leo1 Leo1 IPI00103090 75,359 798 25 17 22%
Leo1 Ctr9 IPI00120919 133,420 960 26 24 17%
Leo1 Cdc73 IPI00170345 60,539 905 27 20 35%
Leo1 Paf1 IPI00331654 60,481 788 18 14 26%
Leo1 Wdr61 IPI00112320 33,752 472 14 10 27%
Leo1 Tceb3 IPI00317167 87,124 378 11 10 13%
Leo1 Polr2a IPI00136207 217,039 153 5 5 2%
Leo1 Smarce1 IPI00119892 46,610 116 2 2 5%
Leo1 RuvB-like 2 IPI00123557 51,081 111 2 2 4%
Leo1 Polr2e IPI00337955 24,555 107 3 3 14%
Wdr61 Wdr61 IPI00019269 33,557 806 19 13 51%
Wdr61 Cdc73 IPI00170345 60,539 208 5 5 13%
Wdr61 Leo1 IPI00474486 75,596 116 2 2 3%
Wdr61 SF3B4 IPI00154082 44,327 196 3 3 10%
Wdr61 RuvB-like 1 IPI00133985 50,182 175 6 6 18%
Wdr61 RuvB-like 2 IPI00123557 51,081 101 3 3 8%
Abbreviations: Baits, Bait used for IP; Name, Name of the gene; ACC_NO, accession number in International Protein Index; Mass, molecular weight
of predicted protein; Score, probability-based MOWSE score of MASCOT software; Matches, number of total matched peptides via MASCOT;
PEP_UNIQ, number of unique peptide sequences identified via MASCOT; SEQ_COV, percentage of predicted protein sequence covered by
matched peptides via MASCOT.
Detailed information on the mass spectrometry analyses is provided in Table S8.Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc. 411requires a detailed and systematic understanding of ESC/iPS
self-renewal and differentiation to develop protocols for safe
tissue replacement therapies.
We performed a genome-scale RNAi screen to initiate a global
survey of genes required to maintain mouse ESC identity. This
screen identified 296 candidate genes with numerous functions
that may influence Oct4 expression levels, suggesting a complex
interplay of several biological processes required to maintain
pluripotency. This data set should present a useful resource to
characterize factors that influence ESC self-renewal and ulti-
mately may also be useful to improve the reprogramming
protocols of somatic cells. Oct4 is one of the factors used to
reprogram somatic cells into iPS cells (reviewed in Jaenisch
and Young, 2008). Thus, identifying the genes that regulate the
expression of Oct4 should be instrumental for understanding
the reprogramming process. Understanding the endogenous
regulation of Oct4 may reveal alternative ways to activate Oct4
expression in somatic cells. As such, the genes that alter the
expression of Oct4 upon RNAi present a good starting point to
unravel the network of Oct4 regulation.Most of the strongest hits identified in our screen are transcrip-
tion factors and/or chromatin modifiers that regulate transcrip-
tional processes. Modulation of transcription activity requires the
interaction of transcription factors, the Pol II basal transcription
machinery, and factors regulating chromatin structure. The enrich-
ment of transcription factors and chromatin modifiers on the one
hand highlights the crucial role of transcription regulation on ESC
fate decision and, on the other hand, offers an opportunity to
unravel the interactions between transcription factors, chromatin
modifiers, and their target DNA for the maintenance of ESC iden-
tity. Here we focused on the Paf1C because we had two indepen-
dent, highly significant, starting hits, and also we were excited by
the potential discovery of a novel regulatory mechanism.
The Paf1C was originally identified in yeast as a specific Pol II-
associated protein complex biochemically distinct from the Srb/
Med-containing Pol II holoenzyme (Shi et al., 1997). Further
genetic and biochemical studies showed that the Paf1C is impli-
cated in transcript start site selection (Stolinski et al., 1997), initi-
ation and elongation (Costa and Arndt, 2000; Mueller and Jaehn-
ing, 2002), poly(A) site utilization (Penheiter et al., 2005), and
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Embryoid Body Formation, and Overex-
pression Blocks ESC Differentiation
(A) Expression changes of indicated genes from
the Paf1C and the mediator complex (Srb-Med)
during EB formation are shown. The heat map
shows data (log2 values) extracted from gene
expression arrays of RNA hybridized from day 1
to day 10 (1d–10d).
(B) Shown are constructs used to transfect the
Sox1-GFP ESCs. Relevant elements and a scheme
of the function of the inducibility of the expression
constructs by doxycycline (Dox, +Dox) is pre-
sented. A western blot analysis shows the induced
expression of Ctr9 after doxycycline treatment.
CAGGs, chicken b-actin promoter coupled to
a CMV early enhancer; irtTA, reverse-tetracycline
repressor; IRES, internal ribosome entry site;
neo, neomycin resistance gene; Ins, chicken
b-globin insulator; tet-op, tetracycline operator-
binding sites; Hyg, hygromycine resistance gene;
AmpR, ampiciline resistance gene; ori, ColE1 ori-
gion of replication.
(C) Scheme of the differentiation assay. Arrows
show possible outcomes after induced expression
of cDNA constructs. The variable amount of GFP
expression in the cells is indicated by different
intensities of green.
(D) FACS profiles and the percentage of GFP-posi-
tive Sox1-GFP cells without (Ctr9 Un_Induced)
and with (Ctr9 Induced) Ctr9 overexpression are
presented.
(E) Comparison of different genes blocking, or
enhancing, differentiation in the Sox-GFP assay.
The percentageofGFP-positivecellsafter transfec-
tion of cDNA constructs of indicated genes, with
and without doxycyline treatment, are presented.
(F) Expression changes of indicated genes upon
overexpression of Ctr9 (induced), or without Ctr9
overexpression (Un_induced), are shown.
(G) Model for Paf1C function in ESCs. The model
depicts the concerted action of pluripotency tran-
scription factors (pTFs), the Paf1C, and the Set1C
to maintain active transcription (H3K4me3) of pluri-
potency genes. GTFs, general transcription factors;
S5-P, phosphorylated serine 5 of the CTD tail of
Pol II; S2-P, phosphorylated serine 2 of the CTD
tail of Pol II. Values in (E) and (F) are means ± SD
from experiments done in triplicate. ** indicates
highly significant (p < 0.01) results based on
Student’s t test analyses.histone methylation (Krogan et al., 2003), suggesting a complex
role of the Paf1C for gene regulation in yeast. In metazoans, the
Paf1C has additionally been implicated in Notch and Wnt
signaling, indicating that this protein complex participates in
biological processes such as oncogenesis and embryogenesis
(Akanuma et al., 2007; Mosimann et al., 2006; Tenney et al.,
2006).
In this manuscript, we demonstrate an important role of the
Paf1C for the maintenance of mouse ESC identity. Knockdown
of all known complex subunits led to a decreased expression
of Oct4 and other pluripotency markers, accompanied by
a loss of ESC self-renewal and subsequent differentiation. These
phenotypic consequences could be rescued by physiological412 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.expression of the human Paf1C components. Global gene
expression analysis after Paf1C depletion revealed a change in
the expression of specific genes, with most known pluripotency
genes being downregulated. This observation was substantiated
by ChIP studies, where the Paf1C was found to directly bind to
the promoters of many pluripotency genes. Hence, the Paf1C
is important for the sustained expression of pluripotency genes
in mouse ESCs. The large overlap of regulated genes upon
Oct4, Nanog, and Ctr9 knockdown argues that the Paf1C is an
integral part of the Oct4-Nanog regulatory circuit. Because the
Paf1C interacts with the Pol II machinery, we hypothesize that
the Paf1C integrates signals from the pluripotency transcription
factors to establish a specialized Pol II complex that maintains
Cell Stem Cell
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Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc. 413active transcription of these genes (Figure 5G). The observed
downregulation of Paf1C components during EB formation and
the block of differentiation upon overexpression further supports
this notion.
The recent identification of ‘‘bivalent’’ promoters carrying both
H3K4me3 and H3K27me3 in ESCs identified a subset of genes
crucial to lineage commitment decisions. To this subset, we
now add another important subset of genes regulated by the
Paf1C, which are crucial to self-renewal. Furthermore, our study
identifies genes whose downregulation may be essential to
initiate differentiation into specific lineages in the developing
embryo.
Because the role of the Paf1C is multifaceted, its role in main-
taining pluripotency may also be complex. Here we show that
the Paf1C is required for the maintenance of H3K4me3 on pluri-
potency genes. The selective binding of the Paf1C to the
promoters of pluripotency genes combined with the synergistic
effect of Paf1C knockdown with a key subunit of the Set1
H3K4 methyltransferase complex indicates a direct role of the
Paf1C in the modulation of chromatin structure at pluripotency
genes in ESCs. In yeast, the Paf1C is required for recruitment
of H3K4 methyltransferase activity to Pol II (Krogan et al.,
2003; Ng et al., 2003b). Our data suggest a similar role of the
Paf1C at pluripotency genes in ESCs. According to this model
(Figure 5G), depletion of the Paf1C would result in a decrease
of the Set1 complex at promoter regions of pluripotency genes,
which consequently would result in the loss of H3K4 trimethyla-
tion. As a result, expression levels of pluripotency genes would
diminish, initiating the differentiation process.
The proteomic analyses of the Paf1C components support an
intricate role of this protein complex in ESCs. Whereas both Ctr9
and Leo1 pulldowns identified most known Paf1C components,
they also revealed specific interactions with other Pol II-associ-
ated factors. Interestingly, some of these specific interactors
have been implicated in ESC pluripotency. For instance,
Tceb3, a Leo1-interacting protein, has been shown to regulate
transcription of a subset of genes linked to cell-cycle progres-
sion in mouse ESCs (Yamazaki et al., 2003).
Lineage-restricted differentiation upon Paf1C depletion was
unexpected. Instead of uniformly exiting from self-renewal into
all four alternatives (trophectoderm, endoderm, ectoderm,
mesoderm), Paf1C-depleted ESCs appear impaired to differen-
tiate toward endoderm. Furthermore, we note that the promoter
region of the endoderm control gene Gata6 was occupied by the
Paf1C before the gene was expressed. Consequently, we spec-
ulate that key endoderm control genes require the Paf1C for the
induction of their expression and that Paf1C plays a specific role
in early endodermal commitment.
In practical terms, the lineage-restricted ESC differentiation
upon Paf1C and Ube2m knockdowns may be useful for the
directed generation of specific cell types from ESCs. To date,
strategies to accomplish this goal mainly rely on overexpression
of lineage commitment genes and the use of certain growth-
factor-enriched media (Turksen, 2001). Our study suggests
that enhanced ESC differentiation protocols can be developed
by combining these protocols with the depletion of certain genes
by RNAi. These experimental modifications should improve the
efficiency for generating specific cell types for experimental or
therapeutic transplantation.In summary, our work provides a global view of ESC pluripo-
tency, revealing that an integrated analysis of transcription,
chromatin structure, signaling, and possibly other biological
processes is needed to fully understand ESC pluripotency. By
analyzing one of the protein complexes in more detail, we have
begun to uncover specific connections between these
processes, in which interplay of transcription factors, Pol II-asso-
ciated factors, and chromatin regulation is needed for maintain-
ing ESC identity. A picture emerges in which specific transcrip-
tion factor combinations work in concert with specialized Pol II
complexes assembled on particularly marked chromatin struc-
tures to control the expression of pluripotency genes.
EXPERIMENTAL PROCEDURES
Mouse esiRNA Library
The templates for the esiRNA synthesis were generated using the cDNA library
Mouse Unigene Set, RZPD 2.1 (Imagenes, http://www.imagenes-bio.de/
products/sets_libraries/non_redundant_sets). EsiRNAs were synthesized as
described previously (Kittler et al., 2005a) and normalized to 100 ng/ml in
384-well plates for the genome-scale screen (Table S1).
Cell Culture and High-Throughput Screen
ESCs (E14TG2a, R1/E, Oct4-Gip [Ying et al., 2002], and BAC-transgenic ESC
lines) were cultured on gelatin-coated plates in Glasgow Minimum Essential
Medium (Sigma) supplemented with 10% FBS (Pan biotech), 2.2 mM L-gluta-
mine, 1 mM sodium pyruvate, 50 mM 2-mercaptoethanol, 13 NEAA (Invitro-
gen), and LIF (generated in house) as previously described (Bernstein et al.,
2006). ESCs were trypsinized and split every 2 days, and the medium was
changed daily. For the genome-scale screen, reverse transfections were per-
formed using mixtures of 20 ng esiRNA and 0.075 ml Lipofectamine 2000 (Invi-
trogen) in 10 ml optimum medium (Invitrogen). ESCs were plated in 384-well
plates with a density of 900 cells per well in 60 ml ESC medium. On each plate,
eight negative controls (Luciferase esiRNA) and eight positive controls (four
GFP esiRNAs, four Sox2 esiRNAs) were placed to monitor the transfection effi-
ciency. GFP fluorescence and cell numbers were measured 96 hr posttrans-
fection using a FACS Calibur (BD Biosciences) equipped with an HTS loader
for high-throughput readout.
Alkaline Phosphatase Staining
ESCs (2 3 103) were reverse transfected with 50 ng esiRNAs and 0.2 ml Lipo-
fectamine 2000 in 96-well plates. Four days posttransfection, ESCs were fixed
in 4% paraformaldehyde (Sigma) for 5 min at room temperature. After two
times rinsing with PBS, ESCs were stained using the Alkaline Phosphatase
Red Microwell Substrate (Sigma).
Western Blotting
Oct4-Gip cells (83 104) were reverse transfected with 800 ng esiRNAs and 2 ml
Lipofectamine 2000 in 6-well plates. Four days posttransfection, ESCs were
harvested, and 10 mg of protein extracts were separated using NuPAGE
4%–12% Bis-Tris protein gels (Invitrogen) and blotted to nitrocellulose
membrane (Millipore). The membranes were probed with the primary anti-
bodies against Stat3 (H-190; sc-7179, Santa Cruz), phospho-Stat3 (Tyr705;
44-380G, Invitrogen), and Gapdh (NB300-221, Novus Biologicals).
RT-qPCR
Total RNA was isolated by using the RNeasy Mini kit (QIAGEN), and 1 mg RNA
was reverse transcribed with SuperScript III Reverse transcriptase (Invitrogen)
utilizing an oligo(dT)18 primer. qPCRs were performed with the SYBR Green
qPCR kit (Abgene) on an MX P3000 qPCR machine (Stratagene). Measured
transcript levels were normalized to Gapdh. Samples were run in triplicate.
Primers used are listed in Table S7.
Gene Expression Analyses
Oct4-Gip cells (83 104) were reverse transfected with 800 ng esiRNAs and 2 ml
Lipofectamine 2000 in 6-well plates. Four days posttransfection, RNA was
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Target Labeling and Control Reagent Package (Affymetrix), as described in the
manufacturer’s instructions. Extracts from four biological replicated were
hybridized to Mouse Genome 430 2.0 arrays (Affymetrix), and the data were
analyzed by hierarchical clustering using Cluster 3.0 software. Affymetrix
data are accessible through the GEO series under accession number
GSE12078.
Cell-Cycle Profiling
Oct4-Gip cells were transfected as for the gene expression analyses. After
96 hr, cells were trypsinized, washed with PBS, and fixed overnight with ice-
cold 70% ethanol. After washing with PBS, cells were stained with PI solution
(25 mg/ml PI, 20 mg/ml RNaseA, 0.02% Triton X-100) for 30 min in the dark, and
the cell-cycle profiles were acquired by FACS.
Cross-Species RNAi Rescue
Cross-species RNAi rescue experiments were performed as previously
described (Kittler et al., 2005b). Briefly, Oct4-Gip and human BAC-transgenic
ESC lines were generated and transfected with esiRNAs, which only target the
mouse transcripts. Mouse-specific esiRNAs were generated by using primers
listed in Table S7. Cells were transfected as for the gene expression analyses.
Four days posttransfection, cells were stained with alkaline phosphstase, and
RNAs from esiRNA-transfected ESCs were prepared by using the RNeasy Mini
kit (QIAGEN) and reverse transcribed with SuperScript III Reverse transcrip-
tase (Invitrogen). qPCRs were performed as described before to quantify the
expression of Cdx2, Fgf5, and Oct4. Samples were run in triplicate, and
measured transcript levels were normalized to Gapdh. To evaluate the speci-
ficity and efficiency of knockdowns, cDNA fragments from HeLa cells, WT
mouse ESCs, human BAC-transgenic ESCs, and human BAC-transgenic
ESCs transfected with esiRNAs were PCR amplified with primers that perfectly
match the human and mouse transcripts (for primers, see Table S7). To
discriminate the human and mouse transcripts, PCR products for Ctr9, Rtf1,
and Leo1 were digested with XhoI, XbaI, and PstI, respectively, and separated
on a 2% agarose gel.
Chromatin Immunoprecipitation and Protein Identification
by Mass Spectrometry
ChIP assays of mouse ESCs were essentially performed as previously
described by Bernstein et al. (2006) using antibodies against H3K4 (Ab8580,
Abcam) and H3K27 (07-449, Upstate). LAP tag-based ChIP assays were per-
formed with BAC-transgenic ESC lines as previously described using a poly-
clonal goat anti-GFP antibody (Poser et al., 2008).
BAC-transgenic ESC lines Ctr9-LAP, Leo1-LAP, Wdr61-LAP, and Rtf1-LAP
were generated by tagging the BACs RP11-77G5, RP11-56B16, RP11-
1132M10, and RP11-16O9, respectively.
Enrichments of target genes were quantified by qPCR with primers listed in
Table S7. Genome-wide location analysis was carried out using mouse
promoter array 1.0R array (Affymetrix). The data are accessible through the
GEO series accession number GSE14654.
GFP-tagged protein complexes were isolated by immunoaffinity chroma-
tography as previously described (Poser et al., 2008) and analyzed by mass
spectrometry. See the Supplemental Data for details.
Overexpression Studies in Sox1-GFP ESCs
The pSport1-tet/Cmv-Ins-Hygro expression constructs contain full-length
cDNAs (Luciferase, Importin-a5, Ctr9, and Klf5) under the control of a tetracy-
cline-inducible CMV-minimal promoter. The Sox1-GFP (46C) ESC line (Ying
et al., 2003), stably expressing a codon-optimized tetracycline activator (irtTA;
Anastassiadis et al., 2002) from the CAGGs promoter, was grown in a chemi-
cally defined medium (ESGRO complete, Millipore) with BMP4 and LIF. The
cells were then trypsinized and plated in RHB-A medium (Stem Cell Sciences)
on gelatin-coated 6-well plates in duplicates and retrotransfected at day 0 with
the tetracycline-inducible plasmids (1 mg each) plus the normalization plasmid
ptet-Gaussia Luciferase (200 ng) in the presence or absence of doxycyline
(1 mg/ml). RHB-A medium was changed daily. At day one, the supernatant
was collected, and the Gaussia luciferase activity was measured to normalize
for transfection efficiencies. At day three, cells were collected, fixed in 2%414 Cell Stem Cell 4, 403–415, May 8, 2009 ª2009 Elsevier Inc.paraformaldehyde, and analyzed by FACS. At the same time, RNA was
extracted for expression analyses by qRTPCR.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, five
figures, and eight tables and can be found with this article online at http://
www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00110-6.
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